ViiV Healthcare, which specializes in medicines and research concerning HIV (human immunodeficiency virus), will continue to bring innovative therapies to China to give infected individuals the right to choose an appropriate treatment plan and make HIV a more relieved part of their lives, a senior company executive said.

ViiV Healthcare是一家专门从事HIV（人类免疫缺陷病毒）药物和研究的公司，该公司的一位高级管理人员表示，该公司将继续将创新疗法带到中国，让感染者有权选择合适的治疗计划，并使HIV成为他们生活中更轻松的一部分。

Prezcobix is a prescription medicine licensed in many countries, including China, for the treatment of human immunodeficiency virus (HIV-1).

Gilead Sciences, which specializes in developing treatments for human immunodeficiency virus (HIV) and liver diseases such as hepatitis B and C, will participate in the CIIE for the second time this year, according to the company's global vice president Jin Fangqian.